SURG vs ENSC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 20, 2026

SURG

61.6
AI Score
VS
SURG Wins

ENSC

43.8
AI Score

Investment Advisor Scores

SURG

62score
Recommendation
BUY

ENSC

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SURG ENSC Winner
Revenue 32.19M 2.13M SURG
Net Income -10.76M -6.13M ENSC
Net Margin -33.4% -288.3% SURG
Operating Income -7.75M -6.14M ENSC
ROE 52.0% 783.8% ENSC
ROA -116.5% -207.2% SURG
Total Assets 9.24M 2.96M SURG
Cash 1.95M 676,704 SURG
Current Ratio 0.19 0.70 ENSC

Relative Price Performance (Last 90 Days)

SURG 1M: -8.6% · 3M: -60.2% ENSC 1M: +11.5% · 3M: +54.2%

Current Technical Phase

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -30.4%), weak momentum, RSI 41

RSI (14): 41.1 · Price: $0.16

ENSC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.1 · Price: $0.42

Fundamentals Snapshot

Metric SURG ENSC
Market Cap
Forward P/E 16.0 -8.4
Trailing P/E
Revenue (TTM)
Revenue Growth 0.4% -0.2%
Gross Margin -0.2% -1.8%
Operating Margin 0.2% -2.2%
EPS -1.49 -2.56
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SURG is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.